MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Archives & Legacy
*Developments: Johnson & Johnson (Archives 2018 -2020)
Parents
*Developments: Johnson & Johnson (J&J)
Archives & Legacy
Organization & Developments: Johnson & Johnson (J&J)
Children
2018: U.S. Army_MEDCOM_Hip Revision
2018: VA_J--Advanced Sterilization Products Annual Service Contract (Sterrad Sterilizers)
2019: Apple, J&J partner on multi-year study of Apple Watch's health features
2019: BARDA/Johnson & Johnson_Reimagining Respiratory Protection
2019: J&J polishes up its new list of late-stage blockbuster candidates
2019: VA_65--Johnson & Johnson Health Care Systems, Inc. On behalf of Janseen Biotech, Inc. 65IB Drugs, Pharmaceuticals and Hematology Related Products 36F79719D0217
2020: AnchorDx, Johnson & Johnson Collaborate on Early-Stage Lung Cancer Diagnosis Study
2020: Apple, J&J launch 150,000-person virtual study to test its ECG smartwatch and heart-focused apps
2020: Arrowhead Is A Buy On Takeda Deal And Massive Pipeline
2020: BARDA_Blue Knight_ J&J, BARDA pick 7 startups to back in fight against COVID-19—and beyond_fiercebiotech
2020: Emergent BioSolution's deal with Johnson & Johnson has geopolitical significance
2020: Guardant Health teams up with Janssen to develop liquid biopsy diagnostic
2020: J&J drops planned 510(k) for Verb-Auris robot, targets 2022 clinical trial start
2020: J&J inks 2nd manufacturing deal to boost capacity for COVID-19 vaccine
2020: J&J readies rivals to da Vinci and Mako, eyeing new markets for robots
2020: J&J-partnered MeiraGTx aims at Biogen with new eye gene therapy data – Endpoints News
2020: J&J, BARDA set early 2021 finish line for $1B vaccine race; FDA allows emergency drug use, ahead of pivotal data – Endpoints News
2020: Janssen launches new accelerator for digital companies focused on predictive diagnostics and precision treatment_mobihealthnews
2020: Johnson & Johnson to start human testing of COVID-19 vaccine next week
2020: Johnson & Johnson: A Coiled Spring Going Into 2021, With 10%-20% Upside Potential
2020: Johnson & Johnson: The Pharma Giant That Continues To GrowJohnson & Johnson: The Pharma Giant That Continues To Grow_seekingalpha.com
2020: Robotics to Be the Driving Force Behind J&J’s Device Unit
2021: Johnson & Johnson And Novavax Data